Which key performance indicators are most effective in evaluating and managing an in vitro fertilization laboratory?


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
07 2020
Historique:
received: 23 04 2020
accepted: 28 04 2020
pubmed: 14 6 2020
medline: 29 4 2021
entrez: 14 6 2020
Statut: ppublish

Résumé

The laboratory is the heart of an in vitro fertilization (IVF) clinic, and a quality management system is critical for its administration. We review the main structural, process, and outcome key performance indicators (KPIs) to provide laboratory managers with concrete tools aimed at enhancing the quality of their work. Three concepts must be stressed when dealing with KPIs in IVF: [1] always consider the three types of indicators (structural, process, and outcome related), [2] carefully adapt the control chart to either promptly identify issues and adopt corrective measures, or redefine the control limits in a process called "progress building," [3] consider that achieving a healthy live birth is a multidisciplinary effort that is subject to several confounders, which must be recognized and accounted for in the analyses. In this regard, future KPIs shared among clinicians and embryologists are desirable to enhance the quality of infertility care for IVF patients.

Identifiants

pubmed: 32532495
pii: S0015-0282(20)30422-2
doi: 10.1016/j.fertnstert.2020.04.054
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-15

Informations de copyright

Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Gemma Fabozzi (G)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Danilo Cimadomo (D)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Roberta Maggiulli (R)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Alberto Vaiarelli (A)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Filippo Maria Ubaldi (FM)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy.

Laura Rienzi (L)

Clinica Valle Giulia, GENERA Centers for Reproductive Medicine, Rome, Italy. Electronic address: rienzi@generaroma.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH